/ZTEK
ZTEK Stock - Zentek Ltd.
Healthcare|Medical - Instruments & SuppliesNASDAQ
$0.74+7.67%
+$0.05 (+7.67%) • Dec 19
58
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.12
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.81
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ZTEK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.73 – $0.75
TARGET (TP)$0.85
STOP LOSS$0.68
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.49
52W High$1.84
52W Low$0.62
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $872,495 | $29,816 | $72,855 | $339,666 | $2,355 |
| Gross Profit | $192,485 | $-301,264 | $-780,481 | $-37,121 | $-193,673 |
| Gross Margin | 22.1% | -1010.4% | -1071.3% | -10.9% | -8223.9% |
| Operating Income | $-9,600,632 | $-11,978,518 | $-14,652,945 | $-12,562,665 | $-4,313,720 |
| Net Income | $-10,039,658 | $-11,703,990 | $-14,414,266 | $-31,694,048 | $-3,868,650 |
| Net Margin | -1150.7% | -39254.1% | -19784.9% | -9330.9% | -164273.9% |
| EPS | $-0.10 | $-0.12 | $-0.14 | $-0.42 | $-0.05 |
Company Overview
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ZTEKBeat Rate
50%
Last 8 quarters
Avg Surprise
-19.1%
EPS vs Estimate
Beats / Misses
4/4
Last 12 quarters
Latest EPS
$-0.02
Q4 2025
EPS Surprise History
Q1 24
-32.5%
$-0.02vs$-0.02
Q2 24
-171.0%
$-0.02vs$-0.01
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 11, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | — | $-0.02 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-0.01 | — | — |
Q2 2025 | Jun 26, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 12, 2025 | — | $-0.01 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-0.02 | — | — |
Q3 2024 | Aug 12, 2024 | — | $-0.02 | — | — |
Q2 2024 | Jun 26, 2024 | $-0.01 | $-0.02 | -171.0% | ✗ MISS |
Q1 2024 | Feb 12, 2024 | $-0.02 | $-0.02 | -32.5% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $-0.02 | $-0.02 | +9.4% | ✓ BEAT |
Q3 2023 | Aug 11, 2023 | $-0.02 | $-0.02 | +11.6% | ✓ BEAT |
Q2 2023 | Jun 29, 2023 | $-0.02 | $-0.01 | +54.9% | ✓ BEAT |
Q1 2023 | Feb 10, 2023 | $-0.03 | $-0.02 | +33.3% | ✓ BEAT |
Q4 2022 | Nov 14, 2022 | $-0.02 | $-0.03 | -33.3% | ✗ MISS |
Q3 2022 | Aug 5, 2022 | $-0.03 | $-0.04 | -25.0% | ✗ MISS |
Q2 2022 | Jun 29, 2022 | — | $-0.04 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.02 | — | — |
Q4 2021 | Nov 29, 2021 | — | $-0.03 | — | — |
Q3 2021 | Aug 27, 2021 | — | $-0.02 | — | — |
Q3 2021 | Jul 28, 2021 | — | $-0.01 | — | — |
Latest News
Zentek Appoints Mohammed Jiwan CEO, Effective Dec. 1
➖ NeutralBenzinga•Nov 25, 2025, 01:34 PM
Zentek shares are trading higher after the company's subsidiary, Albany Graphite, announced it completed further material characterization tests under its critical minerals innovation fund grant.
📈 PositiveBenzinga•Oct 6, 2025, 03:15 PM
Zentek Announces Its Subsidiary, Albany Graphite Corp Completed Further Material Characterization Tests Under Its Critical Minerals Innovation Fund Grant. Results Confirm That Ultra-High Purity Albany Graphite Meets Nuclear Specifications
📈 PositiveBenzinga•Oct 6, 2025, 12:15 PM
Zentek Has Completed The First In Vivo Tests Of The Lead Candidate Countermeasure For Seasonal Influenza; Was Awarded ~$1.1M Through The Government Of Canada's Innovative Solutions Canada
📈 PositiveBenzinga•Sep 18, 2025, 12:28 PM
Zentek CEO Greg Fenton Resigns To Lead Altek Advanced Materials, Effective Immidiately; Both Companies Sign LOI To License ZenGUARD For U.S. Commercialization
📈 PositiveBenzinga•Sep 3, 2025, 09:14 PM
Zentek's Albany Graphite Secures $500,000 From Ontario Government's Critical Minerals Innovation Fund For Albany Graphite Purification And Anode Development Project
📈 PositiveBenzinga•Sep 2, 2025, 12:03 PM
Frequently Asked Questions about ZTEK
What is ZTEK's current stock price?
Zentek Ltd. (ZTEK) is currently trading at $0.74 per share. The stock has moved +7.67% today.
What is the analyst price target for ZTEK?
No analyst price targets are currently available for this stock.
What sector is Zentek Ltd. in?
Zentek Ltd. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.
What is ZTEK's market cap?
Zentek Ltd. has a market capitalization of $0.08 billion, making it a small-cap company.
Does ZTEK pay dividends?
No, Zentek Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALXO
ALX Oncology Holdings Inc.
$1.45
Mkt Cap: $0.1B
AMWL
American Well Corporation
$4.66
Mkt Cap: $0.1B
BYSI
BeyondSpring Inc.
$2.35
Mkt Cap: $0.1B
CRDL
Cardiol Therapeutics Inc.
$1.01
Mkt Cap: $0.1B
GUTS
Fractyl Health, Inc. Common Stock
$2.20
Mkt Cap: $0.2B
HYFT
MindWalk Holdings Corp.
$1.67
Mkt Cap: $0.1B
HYPR
Hyperfine, Inc.
$1.10
Mkt Cap: $0.1B
MBOT
Microbot Medical Inc.
$2.08
Mkt Cap: $0.1B
MGX
Metagenomi, Inc. Common Stock
$1.76
Mkt Cap: $0.1B
QNCX
Quince Therapeutics, Inc.
$3.57
Mkt Cap: $0.2B
Explore stocks similar to ZTEK for comparison